Skip to main content

Table 2 Occupational status at baseline

From: Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months

  

mITT

(n = 282)

mITTe

(n = 212)

Occupational status

   

Employed (full time)

 

172 (61.0)

172 (81.1)

Employed (part time)

 

40 (14.2)

40 (18.9)

Retired

 

12 (4.3)

n. a

Full reduced

 

12 (4.3)

n. a

Incapable of working

 

11 (3.9)

n. a

Part time employment due to (n = 44)

   

Ulcerative colitis

 

8 (20.0)

8 (20.0)

Other reason

 

32 (80.0)

32 (80.0)

Full reduced due to (n = 12)

   

Ulcerative colitis

 

8 (66.7)

n. a

Other reason

 

4 (33.3)

n. a

Reason for incapable of working (n = 11)

   

Ulcerative colitis

 

11 (100.0)

n. a

  1. Data are shown as n (%). mITT: modified intention to treat analysis set, mITTe: all patients of the mITT who had been employed at baseline